Last evening, SyntheticMR announced a fully secured preferential rights issue of SEK 33m.
Atria will invest EUR 23m in the production of meat products at its Sköllersta plant in Sweden.
Redeye returns with additional comments and revisions following AAC Clyde Space’s directed share iss...
Redeye comments on Friday’s press release from Waystream, stating it has secured a big SEK26m order ...
* Raises SEK 26.6m in the rights issue * Reduces working capital needs by up to SEK 30m * Mitigates ...
Redeye is encouraged by AAC’s announcement this morning, where Bonnier Capital, through a directed i...
Redeye briefly comments on Truecaller releasing an update regarding its Q4 2025 revenue development,...
We expect Q4 to show continued positive momentum, supported by recent trends in key franchises and a...
* The rights issue added MSEK 42 before loan offset * Fenja Capital II provides loan facility of MSE...
Smart Eye has successfully issued a SEK300m senior unsecured bond at 3M STIBOR + 7%, which we view a...
Due to longer sales cycles in the UK and Germany, Careium announced its full-year 2025 guidance will...
Inderes delivered solid monthly sales in November with sales increasing by 15% y/y.
Redeye comments on the subscription rate in Active Biotech's rights issue.
We raise our base case after having evaluated the financial situation of Verrica, which raised USD50...
